Group One Trading’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-700
Closed -$2.64K 8682
2025
Q2
$2.64K Buy
+700
New +$2.75K ﹤0.01% 7321
2023
Q4
Sell
-200
Closed -$2.02K 7695
2023
Q3
$2.02K Sell
200
-100
-33% -$1.19K ﹤0.01% 7037
2023
Q2
$3.75K Buy
300
+200
+200% +$2.38K ﹤0.01% 6843
2023
Q1
$1.17K Sell
100
-56,000
-100% -$714K ﹤0.01% 6758
2022
Q4
$596K Buy
56,100
+56,000
+56,000% +$541K ﹤0.01% 2887
2022
Q3
$1K Buy
+100
New +$1.32K ﹤0.01% 7316
2022
Q1
Sell
-13,500
Closed -$535K 8277
2021
Q4
$535K Sell
13,500
-12,100
-47% -$551K ﹤0.01% 4060
2021
Q3
$1.28M Buy
25,600
+17,400
+212% +$949K ﹤0.01% 3138
2021
Q2
$455K Buy
8,200
+2,700
+49% +$144K ﹤0.01% 4320
2021
Q1
$257K Buy
5,500
+3,600
+189% +$174K ﹤0.01% 4757
2020
Q4
$83K Sell
1,900
-15,300
-89% -$564K ﹤0.01% 4690
2020
Q3
$630K Buy
17,200
+11,800
+219% +$401K ﹤0.01% 2638
2020
Q2
$158K Buy
+5,400
New +$149K ﹤0.01% 3570

Other funds holding HCAT

Group One Trading's HCAT Position: Q1 2026 in Review

Group One Trading sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 86 shares — an estimated $162 sold.

Group One Trading first reported a position in HCAT in Q1 2020 and held it in 9 quarters. The position peaked at $116K in Q3 2022. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Group One Trading reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 86 Health Catalyst shares in Q1 2026, an estimated $162.
  • Group One Trading first reported a position in Health Catalyst in Q1 2020 and held it in 9 quarters.
  • Group One Trading's Health Catalyst position peaked at $116K in Q3 2022.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.